Contact this trialFirst, we need to learn more about you.
ABBV-787 for Acute Myeloid Leukemia
Recruiting1 awardPhase 1
Austin, Texas
This trial is assessing a potential new treatment for adults with relapsed/refractory acute myeloid leukemia (AML). About 60 participants will receive ABBV-787 to determine its safety and effectiveness.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.